Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

Nucleic Acids Research

Volumn 43, Issue D1, 2015, Pages D784-D788

  González Galarza, Faviel F ^a,b   Takeshita, Louise Y C ^a   Santos, Eduardo J M ^a,c   Kempson, Felicity ^a   Maia, Maria Helena Thomaz ^c   Da Silva, Andrea Luciana Soares ^c   Teles E Silva, André Luiz ^c   Ghattaoraya, Gurpreet S ^a   Alfirevic, Ana ^a   Jones, Andrew R ^a   Middleton, Derek ^a,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; HLA ANTIGEN; HLA B57 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; HLA ANTIGEN CLASS 1;

ADVERSE DRUG REACTION; ALLELE FREQUENCY NET DATABASE; ARTICLE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC DATABASE; GENETIC POLYMORPHISM; INFECTION; INFORMATION PROCESSING; PRIORITY JOURNAL; DISEASES; GENETICS; HUMAN; IMMUNOLOGY; INTERNET;

DATABASES, GENETIC; DISEASE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPITOPES; GENE FREQUENCY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERNET; RECEPTORS, KIR;

EID: 84941091243     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1166     Document Type: Article

References (14)

1. Gonzalez-Galarza, F. F., Christmas, S., Middleton, D. and Jones, A. R. (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res., 39, D913-D919.
2. Opelz, G. and Dohler, B. (2013) HLA matching and kidney transplantation: beyond graft survival. In: Everly, MJ and Terasaki, PI (eds). Clinical Transplants 2013. Terasaki Foundation Laboratory, Los Angeles, CA, pp. 121-126.
3. Nowak, J. (2008) Role of HLA in hematopoietic SCT. Bone Marrow Transplant., 42 (Suppl. 2), S71-S76.
4. Blackwell, J. M., Jamieson, S. E. and Burgner, D. (2009) HLA and infectious diseases. Clin. Microbiol. Rev., 22, 370-385.
5. Bluestone, J. A., Herold, K. and Eisenbarth, G. (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature, 464, 1293-1300.
6. Klein, J. and Sato, A. (2000) The HLA system. Second of two parts. N. Engl. J. Med., 343, 782-786.
7. Thorsby, E. and Lie, B. A. (2005) HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl. Immunol., 14, 175-182.
8. Alfirevic, A. and Pirmohamed, M. (2010) Drug induced hypersensitivity and the HLA complex. Pharmaceuticals, 4, 69-90.
9. Yip, V. L., Marson, A. G., Jorgensen, A. L., Pirmohamed, M. and Alfirevic, A. (2012) HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin. Pharmacol. Ther., 92, 757-765.
10. Abi-Rached, L., Jobin, M. J., Kulkarni, S., McWhinnie, A., Dalva, K., Gragert, L., Babrzadeh, F., Gharizadeh, B., Luo, M., Plummer, F. A. et al. (2011) The shaping of modern human immune systems by multiregional admixture with archaic humans. Science, 334, 89-94.
11. Robinson, J., Halliwell, J. A., McWilliam, H., Lopez, R., Parham, P. and Marsh, S. G. (2013) The IMGT/HLA database. Nucleic Acids Res., 41, D1222-D1227.
12. Duquesnoy, R. J., Marrari, M., da M. Sousa, L. C., de M. Barroso, J. R., de S. U. Aita, K. M., da Silva, A. S. and do Monte, S. J. (2013) 16th IHIW: a website for antibody-defined HLA epitope Registry. Int. J. Immunogenet., 40, 54-59.
13. Takeshita, L. Y. C., Gonzalez-Galarza, F. F., dos Santos, E. J. M., Maia, M. H. T., Rahman, M. M., Zain, S. M. S., Middleton, D. and Jones, A. R. (2013) A database for curating the associations between killer cell immunoglobulin-like receptors and diseases in worldwide populations. Database, 2013, bat021.
14. Chen, C. J., Cheng, C. F., Lin, H. Y., Hung, S. P., Chen, W. C. and Lin, M. S. (2012) A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system. J. Clin. Pharm. Ther., 37, 647-651.